Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 – PRINCIPLE / University of Oxford Original study (preprint): Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial – medRxiv Commentary: Covid: Asthma drug ‘speeds up recovery at home’ – BBC Related […]

The post RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19 appeared first on Links Medicus.